Shares of AbbVie (NYSE:ABBV) are surging 7% this morning after the pharmaceutical giant reported solid fourth quarter earnings as two key immunology drugs continue to enjoy significant support.

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other stocks. Lee Munder Capital Group Investments, more commonly known as LMCG Investments ...

Below is Validea's guru fundamental report for ABBVIE INC (ABBV). Of the 22 guru strategies we follow, ABBV rates highest using our P/B Growth Investor model based on the published strategy of ...